Skip to main content

Table 5 Quantitative analysis of the incidence of uveitis in the last year before and during the first year of TNF inhibitor treatment in patients with SpA or PsA

From: Occurrence of anterior uveitis in patients with spondyloarthritis treated with tumor necrosis factor inhibitors: comparing the soluble receptor to monoclonal antibodies in a large observational cohort

  Main analysis
n = 350
Sensitivity analysis
n = 351
In the last year before TNF inhibitorUveitis/patient-months, mean (SD)0.0066 (0.0333)0.0066 (0.0333)
Uveitis/100 patient-years7.927.92
In the first year of TNF inhibitorUveitis/patient-months, mean (SD)0.011 (0.080)0.011 (0.080)
Uveitis/100 patient-years13.213.2
p value0.800.69